Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray.
about
Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu statusHER2 testing: a review of detection methodologies and their clinical performanceDevelopment of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybridHER-2/neu oncogene amplification by chromogenic in situ hybridization in 130 breast cancers using tissue microarray and clinical follow-up studies.Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinomaComparison between immunohistochemistry and chromogenic in situ hybridization in assessing HER-2 status in breast cancer.The prevalence and assessment of ErbB2-positive breast cancer in Asia: a literature surveyHuman epidermal growth factor receptor-2 gene amplification in gastric cancer using tissue microarray technology.HER2 evaluation using the novel rabbit monoclonal antibody SP3 and CISH in tissue microarrays of invasive breast carcinomas.Decreased expression of C-erbB-2 and CXCR4 in breast cancer after primary chemotherapy.Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays.Comparison of Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization for Low and High Throughput HER2 Genetic Testing.Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer.The HER2 CISH pharmDx(™) Kit in the assessment of breast cancer patients for anti-HER2 treatment.Chromogenic in-situ hybridization: a viable alternative to fluorescence in-situ hybridization in the HER2 testing algorithm.Reliability of chromogenic in situ hybridization for detecting HER-2 gene status in breast cancer: comparison with fluorescence in situ hybridization and assessment of interobserver reproducibility.HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry.
P2860
Q21195160-1E1E84E0-FB2F-4A60-8295-A313318B3CA1Q28280488-35F20F80-7A66-4A1D-BC3D-358A66235558Q33378811-1471A7C1-D04B-4E12-8737-E382251D8A95Q33631562-1FBD8310-ECED-47F4-A70D-CD662367CEC7Q34064466-17EA201E-AF13-4E2A-9D18-71222F0DADBDQ34424833-60FAF0DC-8FD8-401B-8243-690FC8A1D2A4Q34571349-202D2F32-BEDB-4FBF-92F2-5B131BD8A085Q35670454-9263A27B-AC01-4094-AA09-1DAB8B73327CQ35984457-EDA61D89-D3D1-4551-9F89-06101AD94CEDQ36244131-685E8AD3-A90A-41A0-920A-65A4FB0DE408Q37175922-7A18741A-BC29-4C2C-880E-6EBA1CBD5301Q40161149-5DED14C4-672C-4881-AB7B-1BCD1B2D9D58Q40748887-42361E94-EC42-478D-BC8D-AC2C956198ADQ46431111-BD32767E-13CC-4A3E-BE11-1521F88DA547Q51953747-6B718D4E-6195-4244-AA7C-58D29486FAC2Q52976761-E455D026-A173-4CB3-A298-F4E79CEEE19AQ53597732-25721ADE-BAE4-490E-B565-D5E0559250DF
P2860
Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Comparing fluorescence in situ ...... inoma using tissue microarray.
@ast
Comparing fluorescence in situ ...... inoma using tissue microarray.
@en
Comparing fluorescence in situ ...... inoma using tissue microarray.
@nl
type
label
Comparing fluorescence in situ ...... inoma using tissue microarray.
@ast
Comparing fluorescence in situ ...... inoma using tissue microarray.
@en
Comparing fluorescence in situ ...... inoma using tissue microarray.
@nl
prefLabel
Comparing fluorescence in situ ...... inoma using tissue microarray.
@ast
Comparing fluorescence in situ ...... inoma using tissue microarray.
@en
Comparing fluorescence in situ ...... inoma using tissue microarray.
@nl
P2093
P2860
P1433
P1476
Comparing fluorescence in situ ...... cinoma using tissue microarray
@en
P2093
Jung Young Lee
Jungyeon Kim
Kyeongmee Park
Sungjig Lim
P2860
P304
P356
10.1097/01.MP.0000086487.78558.7D
P50
P577
2003-09-01T00:00:00Z
P6179
1026179811